Anti-p38 (phospho T180 + Y182) antibody
4
(5 Reviews)
|
(248 Publications)
Rabbit Polyclonal MK14 phospho Y182 + T180 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human, Rat samples. Cited in 248 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK14 pY182 + T180.
View Alternative Names
CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A, MAPK14, Mitogen-activated protein kinase 14, MAP kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-binding protein, MAP kinase MXI2, MAX-interacting protein 2, Mitogen-activated protein kinase p38 alpha, Stress-activated protein kinase 2a, CSAID-binding protein, MAP kinase p38 alpha, SAPK2a
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
Paraffin-embedded human heart tissue stained for p38 (phospho T180 + Y182) using ab4822 (right panel) at 1/20 dilution in immunohistochemical analysis followed by HRP-conjugated secondary antibody and DAB staining. Negative control (left panel) staining without primary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
4% PFA-fixed, Triton X-100 permeabilized SH-SY5Y (human neuroblastoma cell line from bone marrow) cells labeling p38 (phospho T180 + Y182) (Panel A : green) using ab4822 at 1 μg/mL in ICC/IF. Secondary antibody : Alexa Flour® 488 Goat Anti-Rabbit IgG at 1/400 dilution. Nuclei (Panel b : blue) were stained with SlowFade® Gold Antifade Mountant with DAPI. F-actin (Panel c : red) was stained with Alexa Fluor® 594 Phalloidin. Panel d is a merged image showing nuclear localization. Panel e is a no primary antibody control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
Paraffin-embedded human brain tissue stained for p38 (phospho T180 + Y182) using ab4822 (right panel) at 1/100 dilution in immunohistochemical analysis followed by HRP-conjugated secondary antibody and DAB staining. Negative control (left panel) staining without primary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
Paraffin-embedded rat heart tissue stained for p38 (phospho T180 + Y182) using ab4822 (right panel) at 1/20 dilution in immunohistochemical analysis followed by HRP-conjugated secondary antibody and DAB staining. Negative control (left panel) staining without primary antibody.
- WB
Unknown
Western blot - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
Peptide Competition : Extracts prepared from HEK-293 (human epithelial cell line from embryonic kidney) cells treated with UV irradiation were resolved on a 10% Tris-glycine gel and transferred to nitrocellulose. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4oC, then were incubated with 0.50 μg/mL ab4822 for two hours at room temperature in a 3% BSA-TBST buffer, following its prior incubation with : the peptide immunogen (1), a generic phosphothreonine containing peptide (2), a generic phosphotyrosine-containing peptide (3), the non-phosphorylated peptide corresponding to the phosphopeptide (4), no peptide (5), the phosphorylated peptide derived from the corresponding region of JNK 1 & 2 (6), and, the phosphorylated peptide derived from the corresponding region of ERK 1 & 2 (7). After washing, membranes were incubated with goat F(ab')2 antirabbit IgG alkaline phosphatase and the signal was detected using the Tropix WesternStar method. The data show that only the phosphopeptide
All lanes:
Western blot - Anti-p38 (phospho T180 + Y182) antibody (ab4822)
Predicted band size: 41 kDa
false
- WB
Supplier Data
Western blot - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
All lanes:
Western blot - Anti-p38 (phospho T180 + Y182) antibody (ab4822) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) exposed for 40 min with UV, cell lysate at 20 µg
Lane 3:
A431 (human epidermoid carcinoma cell line) cell lysate at 20 µg
Lane 4:
A431 (human epidermoid carcinoma cell line) exposed for 40 min with UV, cell lysate at 20 µg
Lane 5:
COLO 205 (human colon adenocarcinoma cell line) cell lysate at 20 µg
Lane 6:
COLO 205 (human colon adenocarcinoma cell line) exposed for 40 min with UV, cell lysate at 20 µg
Lane 7:
A549 (human lung carcinoma cell line) cell lysate at 20 µg
Lane 8:
A549 (human lung carcinoma cell line) exposed for 40 min with UV, cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG HRP at 1/5000 dilution
Predicted band size: 41 kDa
true
- WB
CiteAb
Western blot - Anti-p38 (phospho T180 + Y182) antibody (AB4822)
Western Blotting using Anti-p38 (phospho T180 + Y182) antibody, ab4822. Publication image from He, J. et al., 2020, Mol Cancer, 31992303. Legend direct from paper.
Inhibition of phosphorylation of p38/MAPK reverses cell survival induced by circ-MAPK4. (a) U373 cells transfected with siRNA negative control, circ-MAPK4 siRNA-1 and siRNA-2 were treated with or without p-p38/MAPK inhibitor (SB203580). Inhibition efficiency of p-p38/MAPK inhibitor was accessed by testing phosphorylation and total protein levels of p38/MAPK and ERK using western blot assays. (b, c) CCK-8 and colony formation assays were performed to reveal cell survival of these U373 cells. (d) Apoptosis assays were performed to reveal apoptosis levels of these U373 cells. (e) The western blot assays were used to evaluate effect of p-p38/MAPK inhibitor on protein expression levels of cleaved form of caspase-9, caspase-7, caspase-3, PARP1 in these U373 cells. The data were summarized as bar graph. Data are the means ± SEM of three experiments. *P < 0.05; **P < 0.01; ***P < 0.001
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P38 is involved in several cellular processes such as inflammation cell differentiation and apoptosis. It often functions as part of a MAPK signaling complex where it serves a critical role in transmitting signals from the cell surface to the nucleus. It interacts with upstream kinases for activation and affects cellular responses by phosphorylating transcription factors and other protein kinases. Through experiments using techniques like p38 western blot and alpha ELISA scientists can monitor its activity and understand its role in cellular physiology.
Pathways
P38 signaling is integral to both the MAPK and NF-kB pathways. It helps mediate several cellular responses including inflammation and stress responses. Within these pathways p38 interacts with other proteins such as JNK and ERK which helps regulate adaptive and innate immune responses. These interactions ensure distinct yet overlapping signaling responses necessary for cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (248)
Recent publications for all applications. Explore the full list and refine your search
International journal of ophthalmology 18:1426-1432 PubMed40827285
2025
Applications
Unspecified application
Species
Unspecified reactive species
Food science & nutrition 13:e70692 PubMed40786825
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 82:269 PubMed40610735
2025
Applications
Unspecified application
Species
Unspecified reactive species
Hereditas 162:119 PubMed40604895
2025
Applications
Unspecified application
Species
Unspecified reactive species
Purinergic signalling 21:565-576 PubMed40560521
2025
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 19:4689-4715 PubMed40486125
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 16:289 PubMed40483498
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:18912 PubMed40442166
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 182:2897-2913 PubMed40097259
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1536143 PubMed40092994
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com